Thumbnail Image

Kerala Veterinary and Animal Sciences University, Wayanad

Browse

2017 - 20192
Reset filters
Subject: Veterinary Microbiology × End date: 2019 × Start date: 2010 × Thesis Type: Ph.D ×
Reset filters

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    ThesisItemOpen Access
    DEVELOPMENT OF A MODIFIED INACTIVATED VACCINE AND ITS COMBINATION WITH A RECOMBINANT PROTEIN AGAINST LEPTOSPIROSIS
    (COLLEGE OF VETERINARY AND ANIMAL SCIENCES MANNUTHY, THRISSUR, 2017-12-30) MANJU SOMAN; M.Mini
    The study was taken up with an aim to develop a foolproof technique for prevention of leptospirosis. It involved the development and immunity evaluation of a modified whole cell inactivated vaccine incorporating the predominant leptospiral serovars, Australis, Autumnalis and Pomona in hamsters. The study also ascertained the genus specific immunoreactivity of a truncated recombinant leptospiral LigA protein and its combination with the modified inactivated vaccine, in hamsters. The immunomodulatory effect of incomplete Freund’s adjuvant (IFA) and the aluminium hydroxide gel adjuvant in hamsters was also assessed. Primers were designed for a highly immunodominant region of the ligA gene, spanning nucleotides from 1873 to 3363. The PCR amplified 1491 bp fragment of ligA DNA was cloned into pET -32a vector and expressed in E.coli BL21(DE3). The conditions optimum for expression of this recombinant protein were analysed. Maximum expression was obtained following induction with 2 mM IPTG, at an incubation temperature of 28o C following six hours of incubation at 200 rpm shaking speed. The Ni-NTA purified rLigA protein was used for immunization of hamsters. The optimum concentration of the rLigA protein and modified inactivated vaccine required for immunisation of hamsters, was determined by immunising four sets of hamsters with four different concentrations of the antigens, 14 days apart. It was revealed that the concentration of 80µg/ 40 µg of Lig A protein and 108 leptospires per millilitre gave the maximum IgG ELISA and MAT titres.Six vaccine groups were set up for six different vaccine combinations which included the modified inactivated vaccine, rLigA protein and a combination of the modified inactivated vaccine and rLigA protein. Adjuvants IFA and aluminium hydroxide were used in the study. The serum antibody titres on days 0, 7,14 and 27 were determined by MAT and recombinant IgG ELISA The virulence of laboratory strains of Leptospira interrogans serovars Pomona (homologous) and Icterohaemorrhagiae (heterologous) was enhanced by serial passage in hamsters and these were used as challenge organisms in the study. The LD50, of the serovars Pomona and Icterohaemorrhagiae, in hamsters was determined as 106.893 organisms and 107.38 organisms, respectively and the challenge was carried out with 100 LD50 (≈109 ) organisms, on 28th day post first immunization. Challenge studies revealed maximum protection levels of 80 to 100 per cent in groups immunised by modified inactivated vaccine alone and combination of rLigA and inactivated vaccine. Groups immunised with rLigA protein alone showed 60-70 per cent protection to both serovars. The highest MAT titres to homologous and heterologous serovars were presented by the groups immunized with a combination of rLigA protein and modified inactivated vaccine. These groups elicited higher MAT titres to heterologous serovar Icterohaemorrhagiae compared to whole cell vaccine alone, which indicated the genus specificity contributed by the partial rLigA protein. It also showed that the inactivated vaccine and recombinant protein compliment each other in increasing the respective immunogenicity. The study revealed that IFA adjuvanted rLigA protein could elicit the maximum ELISA titres in hamsters, followed by the group immunised by IFA adjuvanted rLigA protein combined with modified inactivated vaccine. The IFA adjuvanted vaccine groups showed higher ELISA titres compared to those adjuvanted with aluminium hydroxide but the aluminium hydroxide adjuvanted vaccine groups showed consistent increase in antibody titres.
  • Thumbnail Image
    ThesisItemOpen Access
    ASSESSMENT OF CELL MEDIATED AND HUMORAL IMMUNE RESPONSE TO SUBUNIT VACCINE AGAINST RIEMERELLOSIS
    (COLLEGE OF VETERINARY AND ANIMAL SCIENCES MANNUTHY, THRISSUR, 2019-12-30) RINSHA BALAN; Priya P. M.
    Riemerellosis is a bacterial disease among ducks, caused by Riemerella anatipestifer, which has been well documented as a cause of considerable economic loss to the duck production in Kerala. At least 21 serotypes of the organism have been identified globally. Since vaccination is the mainstay for the control of the disease, a research work was undertaken to prepare subunit vaccine employing recombinant OmpA of R. anatipestifer and assessment of cell mediated and humoral immune responses of the vaccine and also to evaluate the comparative efficacy with that of the developed inactivated vaccine. Broth culture of R. anatipestifer at a concentration of 2.5 OD values at 525 nm with a dose of 1 mL per bird subcutaneously was selected as LD50. L per bird subcutaneously was selected as LD50. A total of 52, day-old ducklings were divided into three treatment groups with ten birds each. They were injected with 0.5 mL of different types of vaccine subcutaneously. Group I (T1) served as control with 22 birds including six birds each for challenge control of inactivated and subunit vaccine. Group II (T2) was injected with an inactivated vaccine (7x109 cfu/mL), which was prepared as per the protocol standardised in the Department of Veterinary Microbiology and group III (T3) and group IV (T4) were administrated with different antigen concentration of subunit vaccine (equal quantity of the rompA protein (250µg and 500µg) and montanide, respectively). A booster dose was given at third week post-primary vaccination to T2, T3 and T4. It was observed that, by using both crude Omp and rOmpA based ELISA, inactivated vaccine birds (T2) produced higher antibody titre during early age while in the subunit vaccine group, the titre was higher during later stage. An early antibody response is required to lower the mortality rate in riemerellosis as the organism targets young ducklings. Thus, it could be inferred from this study that inactivated vaccine was more effective than subunit vaccine A significant CMI response was also shown by inactivated vaccine groups on 14th and 28th day post-vaccination by lymphocyte proliferation assay (LPA). Challenge studies to assess the protective response revealed 100 per cent protection for inactivated vaccine group (T2), 80 per cent protection for T4 group and 70 percent protection for T3 group. All the vaccinated birds were having significantly less gross lesion when compared to the challenge control groups. On analysing the cytokine mRNA expression levels using real-time PCR, the inactivated vaccine group showed significantly higher (p< 0.05) mRNA levels of IL-6, IL-12B and IFN-γ gene on day 28 than the two subunit vaccine groups. It was found that the inactivated vaccine was superior in terms of results obtained from the challenge study, antibody titre, CMI response and gene expression analysis than the subunit one. Hence, it is desirable to advocate the use of inactivated vaccine in field condition owing to its easiness to prepare and low cost.